Psycho-emotional health and quality of life of patients with external genital endometriosis

• Elvira I. Babaeva
• Armen O. Dukhin
• Marianna Z. Abitova

Abstract

Background. Endometriosis takes the second place in the structure of gynecological morbidity, which in turn naturally had a negative impact on the reproductive health of women. The recurrence rate of endometriosis after surgical treatment is 6.4% after 2 years, 10% after 3 years and 30.9% after 8 years.

The aim of this work is to evaluate and improve the results of surgical treatment and the quality of life in patients with external genital endometriosis (EGE).

Material and methods. To solve the problems posed in this work, 130 patients with external genital endometriosis were examined after surgical treatment. All patients after surgery were divided into 2 groups, depending on the degree of spread of endometriosis: group I (n=71) are patients with I, II degree of EGE spread and group II (n=59) of a patient with III, IV degree of EGE spread. Then, in each group, sexual functions and quality of life were evaluated using special scales and questionnaires.

Results. When analyzing the severity of pain according to VAS assessment, the data of the representatives of the selected groups do not differ and fluctuate around 5 points (5.17±2.87), which corresponds to moderate pain. We did not find a correlation between the severity of pain and the degree of spread of OGE. In the studied groups, the relative weight of the development of anxiety is rather high: 42.9% suffered from manifestations of reactive anxiety and 35.3% - from personal anxiety. A high level of depressive and anxiety states was noted, while in Group II with severe stages of EGE these indicators are significantly higher (64.4 versus 24.8%). In the personality profiles of patients in group II, a tendency toward the psycho-atsenic profile of the personality is noticeable.

Conclusion. The data obtained indicate the relevance of this problem, the need for a differentiated approach to this category of patients, as well as the presence of many unresolved issues that require further study.

Keywords:external genital endometriosis, endometrioid disease, reproductive health, quality of life

References

1. Adamyan L.V., Aznaurova Ya.B. Review of modern data concerning molecular aspects of endometriosis is presented. Problemy reproduktsii [Problems of Reproduction]. 2016; 21 (2): 66-77. (in Russian)

2. Borisova A.V., Kozachenko A.V., Frankevich V.E., Chagovets V.V., Kono-nokhin A.S., Starodubtseva N.L., et al. Risk factors for recurrence of external genital endometriosis after surgical treatment: prospective cohortant study Meditsinskiy sovet [Medical Council]. 2018; (7): 32-8. (in Russian)

3. Gromova Т.А., Sheshukova N.A., Bolshakova O.V., Zairatyants O.V., Levakov S.A., Fedotov, E.V. The possibility of neoplastic transformation of ovarian endometriosis. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2018; (3): 96-101. (in Russian)

4. Zakirova Y.R., Babaeva E.I., Orazov M.R., Aryutin D.G. Complex assessment of reproductive health in patients with external genital endometriosis after surgery. Che-lovek. Sport. Meditsina [Human. Sport. Medicine]. 2016; 16 (4): 32-42. (in Russian

5. Orazov M.R. Debating points of endometriosisAkusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2016; (3): 72-84. (in Russian)

6. Pechenikova V.A., Akopyan R.A. Etiopathogenesis of internal and external genital endometriosis (evolution of views). Vestnik Rossiyskoy voenno-meditsinskoy akademii [Bulletin of the Russian Military Medical Academy]. 2018; (2): 234-9. (in Russian)

7. Sukhikh G.T., Adamyan L.V., Serov V.N., Andreeva E.N., Baranov I.I., Dubrovina S.O. and others. Resolution of the expert meeting on the topic “Possibilities of personalization of endometriosis hormone therapy using dydrogesterone.Problemy re-produktsii [Problems of Reproduction]. 2018; 24 (5): 41-4. (in Russian)

8. Brown J., Farquhar C. An overview of treatments for endometriosis. JAMA. 2015; 313 (3): 296-7.

9. Denny E., Weckesser A., Jones G., Bibila S., Daniels J., Bhattacharya S.; PREEMPT team. Women’s experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: a qualitative study. Pilot Feasibility Stud. 2018; 4: 168.

10. De Sanctis V., Matalliotakis M., Soliman A., Elsefdy H., Di Maio S., Fiscina B. A focus on the distinctions and current evidence of endometriosis in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018; 15: 138-50.

11. Isidor B. Familial deep endometriosis: a rare monogenic disease? Eur J Obstet Gynecol Reprod Biol. 2018; 221: 190-3.

12. Fu J., Song H., Zhou M., Zhu H., Wang Y., Chen H., et al. Progesterone receptor modulators for endometriosis. Cochrane Database Syst Rev. 2017; 7: CD009881.

13. Gibson D.A., Simitsidellis I., Collins F., Saunders P.T.K. Endometrial intra-crinology: oestrogens, androgens and endometrial disorders. Int J Mol Sci. 2018; 19 (10).

14. Hwang H., Chung Y.J., Lee S.R., Park H.T., Song J.Y., Kim H., et al. Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis. Obstet Gynecol Sci. 2018; 61 (5): 553-64.

15. Lethaby A., Puscasiu L., Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev. 2017; 11: CD000547.

16. Piepenbrink A., Failing K., Riesenbeck A., Schmid P., Hoffmann B. Down-regulation of LH in the bitch after application of the GnRH-agonist buserelin as a slow-release implant. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2017; 45 (3): 14752.

17. Zheng W., Cao L., Xu Z., Ma Y., Liang X. Anti-angiogenic alternative and complementary medicines for the treatment of endometriosis: a review of potential molecular mechanisms. Evid Based Complement Alternat Med. 2018; 2018: 4128984.

18. Vercellini P., Buggio L., Berlanda N., Barbara G., Somigliana E., Bosari S. Es-trogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016; 106 (7): 15 520-71.

19. Santali Р., Tran С., Gayet V., Bourdon M., Maignien C., Marcellin L., et al. Oligo-anovulation is not a rarer feature in women with documented endometriosis. Fertil Steril. 2018; 110 (5): 941-8.

20. Saridogan E. Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2017; 209: 46-9.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)